Co-Diagnostics seeks FDA clearance for COVID-19 Test and diagnostic instrument

Co-Diagnostics, Inc. (Nasdaq: CODX), a pioneering molecular diagnostics company, has reached a pivotal milestone by completing its first U.S. Food and Drug Administration (FDA) application ... Read More